Skip to content
Sweat Explained

Research

Antimicrobial Peptides in Sweat: Dermcidin and Skin Defense

Human sweat is more than water and salt. Eccrine sweat glands constitutively secrete dermcidin, an antimicrobial peptide first described in 2001 that forms part of the skin's innate immune defense. A proteolytically processed 47-amino-acid fragment is generated in sweat and shows activity against a broad range of bacteria and fungi. Unusually for an antimicrobial peptide, its most abundant sweat form carries a net negative charge, and it stays active across the salty, mildly acidic conditions found on sweaty skin. This page summarizes the verified research on dermcidin, with every figure traced to its source.

By the Sweat Explained Editorial Team · Published 2026-07-13 · Last reviewed 2026-07-13 · Educational information, not medical advice.

Key statistics at a glance

  • 47 amino acids

    length of the processed dermcidin peptide generated in eccrine sweat

    Schittek 2001, Nat Immunol

  • net charge −2

    the dominant sweat form DCD-1L is anionic, uncommon among antimicrobial peptides, which are usually cationic

    Paulmann 2012, J Biol Chem

  • broad spectrum

    active against S. aureus (including MRSA), E. coli, E. faecalis, C. albicans and more

    Paulmann 2012

  • salt- & pH-stable

    activity maintained over a broad pH range and at high salt concentrations resembling human sweat

    Schittek 2001; Paulmann 2012

  • 136.7 vs 9.8 µg/ml

    median dermcidin in sweat of healthy subjects vs patients with acne vulgaris

    Nakano 2015, Acta Derm Venereol

What dermcidin is and where it comes from

Dermcidin was identified in 2001 by Schittek and colleagues, who reported a gene encoding a peptide with a broad spectrum of antimicrobial activity and no homology to previously known antimicrobial peptides. The protein is specifically and constitutively expressed in the eccrine sweat glands, secreted into sweat, and transported to the epidermal surface, meaning it is present in ordinary sweat rather than switched on only during infection.

In sweat, the secreted protein is cut by proteases into shorter fragments. Schittek's team characterized a 47-amino-acid processed peptide that showed antimicrobial activity against a variety of pathogenic microorganisms. Later work showed that several related fragments (collectively called dermcidin-derived, or DCD, peptides) are generated, of which the 48-residue form DCD-1L is the most abundant in sweat.

Because it is made continuously and reaches the skin surface with sweat, dermcidin is generally described as part of the skin's innate immune system, a first-line, non-specific chemical barrier that helps limit colonization by potential pathogens in the first hours after they land on the skin.

What dermcidin peptides act against

Dermcidin-derived peptides have a broad and overlapping antimicrobial range spanning Gram-positive and Gram-negative bacteria and some fungi. The organisms below were reported as susceptible in the structure–activity analysis of DCD-1L and the original characterization; this is laboratory activity, not a claim about treating infection.

Microorganisms reported susceptible to dermcidin-derived peptides
MicroorganismTypeSource
Staphylococcus aureus (incl. MRSA)Gram-positive bacteriumPaulmann 2012
Staphylococcus epidermidisGram-positive bacteriumPaulmann 2012
Enterococcus faecalisGram-positive bacteriumPaulmann 2012
Listeria monocytogenesGram-positive bacteriumPaulmann 2012
Escherichia coliGram-negative bacteriumPaulmann 2012
Salmonella typhimuriumGram-negative bacteriumPaulmann 2012
Cutibacterium (Propionibacterium) acnesGram-positive bacteriumNakano 2015
Candida albicansFungus (yeast)Paulmann 2012

In vitro susceptibility reported in primary studies. Dermcidin is a component of normal skin defense, not an approved antimicrobial treatment.

An unusual anionic peptide that tolerates salt and acid

Most classical antimicrobial peptides, such as the human cathelicidin LL-37 or the defensins, are cationic (net positive charge) and kill microbes largely by disrupting their negatively charged membranes. Dermcidin is different: its dominant sweat form, DCD-1L, is a 48-residue peptide with a net charge of −2 at neutral pH, making it an anionic antimicrobial peptide.

This matters because it survives the environment sweat creates. Both the original 2001 study and the 2012 structure–activity analysis found that dermcidin's activity is maintained over a broad pH range and at the high salt concentrations that resemble human sweat, conditions that inactivate many other antimicrobial peptides. Researchers have proposed that in salty, slightly acidic sweat the peptide can form ion channels in microbial membranes, though the exact killing mechanism is still debated and dermcidin has not been shown to permeabilize membranes as reliably as classical cationic peptides.

Dermcidin levels can be lower in some skin conditions

Several studies have measured dermcidin in collected sweat and found reduced amounts in people with certain inflammatory skin conditions. In one study of acne vulgaris, total dermcidin in sweat was markedly lower than in healthy controls (medians shown below); ranges overlapped and the sample was small.

Median dermcidin concentration in sweat: healthy subjects vs acne vulgaris (Nakano 2015)
Median dermcidin concentration in sweat: healthy subjects vs acne vulgaris (Nakano 2015)
GroupValue
Healthy subjects136.7 µg/ml (range 45.4–201.6)
Acne vulgaris9.8 µg/ml (range 6.9–95.3)

Source: Nakano et al., Acta Derm Venereol 2015;95(7):783–6. Chart is an original rendering of the cited data.

Why reduced dermcidin has drawn interest

The interest in dermcidin levels comes largely from atopic dermatitis (eczema), where patients are prone to recurrent bacterial and viral skin infections and heavy colonization with Staphylococcus aureus. Rieg and colleagues (2005) reported that the amount of several dermcidin-derived peptides in the sweat of patients with atopic dermatitis was significantly reduced, and that sweating lowered the number of viable bacteria on the skin surface in healthy people but not in patients with atopic dermatitis. The acne study above found a similar pattern of lower dermcidin.

These are associations, not proof that low dermcidin causes the skin conditions. Sample sizes are small, measurement methods differ between studies, and skin disease can affect sweat composition as well as the other way around. The findings are best read as evidence that dermcidin is a real, measurable part of skin defense, not as a diagnostic test or treatment target for the general public.

The plain-language takeaway

Sweat contributes to skin defense, not just cooling. Dermcidin is a genuine, well-documented antimicrobial peptide that eccrine glands release continuously, and it stays active in the salty, acidic film sweat leaves on the skin. It is one of several antimicrobial factors on the skin surface (others include the cathelicidin LL-37 and defensins), and no single peptide is solely responsible for keeping skin flora in check.

Everyday sweating, hygiene, and a healthy skin barrier all interact. Nothing here suggests sweating more is protective or that antiperspirants remove this defense; those questions are not answered by the dermcidin literature.

Methodology and limitations

This page draws on primary peer-reviewed studies: the original identification of dermcidin (Schittek 2001, Nature Immunology), the structure–activity analysis of the dominant sweat peptide DCD-1L (Paulmann 2012, Journal of Biological Chemistry), the atopic-dermatitis deficiency study (Rieg 2005, Journal of Immunology), and a concentration study in acne vulgaris (Nakano 2015, Acta Dermato-Venereologica). Each figure was traced to its source and confirmed.

Limitations: antimicrobial activity described here is largely from in vitro (laboratory) experiments and does not translate directly into infection-fighting in daily life. Concentration studies in disease are small and use different assays, so absolute microgram figures are not comparable across studies and the ranges overlap. Lower dermcidin in a skin condition is an association, not established cause. This page is general science education, not medical advice, diagnosis, or a basis for any treatment decision.

Frequently asked questions

What is dermcidin?
Dermcidin is an antimicrobial peptide made continuously by the eccrine sweat glands and released onto the skin in sweat. It was identified in 2001 and is considered part of the skin's innate immune defense (Schittek 2001).
Does sweat really help fight germs?
Sweat carries antimicrobial peptides including dermcidin, which show activity against a range of bacteria and fungi in the laboratory. This is one component of skin defense. It does not mean sweating more protects you from infection.
What makes dermcidin unusual?
Most antimicrobial peptides are positively charged; dermcidin's main sweat form (DCD-1L, 48 residues) carries a net negative charge and stays active in the high salt and broad pH of sweat, conditions that inactivate many other peptides (Paulmann 2012).
Which microbes does dermcidin act against?
Reported susceptible organisms include Staphylococcus aureus (including MRSA), Staphylococcus epidermidis, Enterococcus faecalis, Escherichia coli, Cutibacterium acnes, and the yeast Candida albicans, based on laboratory studies, not treatment of infections.
Is low dermcidin a cause of eczema or acne?
Not established. Studies found reduced dermcidin in sweat of people with atopic dermatitis and acne, but these are associations from small studies. Skin disease can affect sweat composition, so the direction of cause is unclear (Rieg 2005; Nakano 2015).
Can dermcidin be used as a treatment?
It is not an approved medicine. Dermcidin is studied as a natural component of skin defense and as a lead for antimicrobial research; nothing here should be read as a treatment recommendation.

Sources

Primary peer-reviewed studies and official sources first, then reviews and institutional framing (secondary).

  1. Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol. 2001;2(12):1133–1137. PubMed
  2. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, Garbe C, Schittek B. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol. 2005;174(12):8003–8010. PubMed
  3. Paulmann M, Arnold T, Linke D, Ozdirekcan S, Kopp A, Gutsmann T, et al. Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem. 2012;287(11):8434–8443. Full text
  4. Nakano T, Yoshino T, Fujimura T, Arai S, Mukuno A, Sato N, Katsuoka K. Reduced expression of dermcidin, a peptide active against Propionibacterium acnes, in sweat of patients with acne vulgaris. Acta Derm Venereol. 2015;95(7):783–786. PubMed

How to cite this page

Sweat Explained. Antimicrobial Peptides in Sweat: Dermcidin and Skin Defense. Published 2026-07-13; last reviewed 2026-07-13. Available at: https://sweatexplained.com/research/antimicrobial-peptides-in-sweat-dermcidin

Please cite the original studies for the underlying figures. Journalists are welcome to link to this page; the charts are original renderings of the cited data.